Primary Peritoneal Carcinoma Completed Phase 2 Trials for Platinum (DB12257)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01669226First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian CancerTreatment